IL49359A - Condensation products of erythromycylamines with aliphaticor araliphatic aldehydes their preparation and pharmaceutical compositions containing them - Google Patents

Condensation products of erythromycylamines with aliphaticor araliphatic aldehydes their preparation and pharmaceutical compositions containing them

Info

Publication number
IL49359A
IL49359A IL49359A IL4935976A IL49359A IL 49359 A IL49359 A IL 49359A IL 49359 A IL49359 A IL 49359A IL 4935976 A IL4935976 A IL 4935976A IL 49359 A IL49359 A IL 49359A
Authority
IL
Israel
Prior art keywords
erythromycylamines
aliphaticor
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL49359A
Other languages
English (en)
Other versions
IL49359A0 (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25768725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL49359(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2515075A external-priority patent/DE2515075C2/de
Priority claimed from DE19762606030 external-priority patent/DE2606030A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL49359A0 publication Critical patent/IL49359A0/xx
Publication of IL49359A publication Critical patent/IL49359A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL49359A 1975-04-07 1976-04-06 Condensation products of erythromycylamines with aliphaticor araliphatic aldehydes their preparation and pharmaceutical compositions containing them IL49359A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2515075A DE2515075C2 (de) 1975-04-07 1975-04-07 Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19762606030 DE2606030A1 (de) 1976-02-14 1976-02-14 Neue erythromycinderivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
IL49359A0 IL49359A0 (en) 1976-06-30
IL49359A true IL49359A (en) 1979-07-25

Family

ID=25768725

Family Applications (1)

Application Number Title Priority Date Filing Date
IL49359A IL49359A (en) 1975-04-07 1976-04-06 Condensation products of erythromycylamines with aliphaticor araliphatic aldehydes their preparation and pharmaceutical compositions containing them

Country Status (29)

Country Link
US (1) US4048306A (es)
JP (1) JPS51128991A (es)
AT (1) AT342770B (es)
AU (1) AU498418B2 (es)
BG (1) BG27380A3 (es)
CA (1) CA1060005A (es)
CH (2) CH621800A5 (es)
CS (1) CS196304B2 (es)
DD (1) DD125218A5 (es)
DK (1) DK138656C (es)
ES (2) ES446737A1 (es)
FI (1) FI63244C (es)
FR (1) FR2306703A1 (es)
GB (1) GB1520963A (es)
GR (1) GR60374B (es)
HU (1) HU175186B (es)
IE (1) IE43598B1 (es)
IL (1) IL49359A (es)
LU (2) LU74702A1 (es)
MX (1) MX3277E (es)
NL (1) NL180107C (es)
NO (1) NO141411C (es)
NZ (1) NZ180529A (es)
PL (1) PL101880B1 (es)
PT (1) PT64977B (es)
RO (1) RO68441B (es)
SE (1) SE425566B (es)
SU (1) SU682134A3 (es)
YU (1) YU87676A (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO860901L (no) 1985-03-12 1986-09-15 Beecham Group Plc Fremgangsmaate for fremstilling av farmasoeytisk aktive erytromycinderivater.
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
CA2096969C (en) * 1990-11-28 2000-11-21 Masato Kashimura 6-0-methylerythromycin a derivatives
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
ZA922776B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical compounds
SK279270B6 (sk) * 1991-09-30 1998-08-05 Eli Lilly And Company Patent Division Lilly Corpor Spôsob jednostupňovej prípravy diritromycínu
DE4410637C1 (de) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injizierbare Lösungen von Dirithromycin
AU9645998A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US6436906B1 (en) 2001-04-02 2002-08-20 Enanta Pharmaceuticals, Inc. 9-amino-14-membered macrolides derived from leucomycins
WO2005009368A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US8758820B2 (en) 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004270170B2 (en) * 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660376A (en) * 1970-09-30 1972-05-02 Lilly Co Eli N-arylidene erythromycylamines

Also Published As

Publication number Publication date
PT64977B (de) 1978-04-03
FR2306703B1 (es) 1979-10-12
SE7604052L (sv) 1976-10-08
JPS51128991A (en) 1976-11-10
ES456567A1 (es) 1978-03-01
NO141411C (no) 1980-03-05
FI63244C (fi) 1983-05-10
ATA149976A (de) 1977-08-15
DD125218A5 (de) 1977-04-06
NO761172L (es) 1976-10-08
MX3277E (es) 1980-08-15
NL180107B (nl) 1986-08-01
FR2306703A1 (fr) 1976-11-05
RO68441A (ro) 1983-04-29
BG27380A3 (en) 1979-10-12
FI760845A (es) 1976-10-08
FI63244B (fi) 1983-01-31
PT64977A (de) 1976-05-01
GB1520963A (en) 1978-08-09
IL49359A0 (en) 1976-06-30
YU87676A (en) 1982-08-31
AU1272276A (en) 1977-10-13
CS196304B2 (en) 1980-03-31
PL101880B1 (pl) 1979-02-28
NZ180529A (en) 1978-09-20
US4048306A (en) 1977-09-13
SU682134A3 (ru) 1979-08-25
NL180107C (nl) 1987-01-02
AU498418B2 (en) 1979-03-15
AT342770B (de) 1978-04-25
IE43598L (en) 1976-10-07
SE425566B (sv) 1982-10-11
CH621800A5 (es) 1981-02-27
LU88563I2 (fr) 1995-03-21
LU74702A1 (es) 1977-06-03
RO68441B (ro) 1983-04-30
GR60374B (en) 1978-05-23
IE43598B1 (en) 1981-04-08
CA1060005A (en) 1979-08-07
ES446737A1 (es) 1977-10-16
JPS62158B2 (es) 1987-01-06
HU175186B (hu) 1980-05-28
CH624413A5 (es) 1981-07-31
DK138656B (da) 1978-10-09
DK145276A (da) 1976-10-08
DK138656C (da) 1979-04-02
NL7603569A (nl) 1976-10-11
NO141411B (no) 1979-11-26

Similar Documents

Publication Publication Date Title
IL49359A (en) Condensation products of erythromycylamines with aliphaticor araliphatic aldehydes their preparation and pharmaceutical compositions containing them
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL38687A (en) Omega-imidazolyl-omega-phenoxy-alkanones,their preparation and pharmaceutical compositions containing them
IL35781A0 (en) New derivatives of aminopropiophenone,their preparation and pharmaceutical compositions containing them
IL58978A0 (en) Peptidyl-arginne aldehyde derivatives their preparation and pharmaceutical compositions containing them
IL50815A0 (en) New aminobenzoamides their preparation and pharmaceutical compositions containing them
IL50631A0 (en) 1-benzazolylalkyl-4-substituted-piperidines,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL47329A (en) Pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
IL38699A (en) Furfuryl derivatives of 6,7-benzomorphane,their preparation and pharmaceutical compositions containing them
IL49629A0 (en) New derivatives of 2-phenylamino-2-imidazoline,their preparation and pharmaceutical compositions containing them
IL33846A0 (en) Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them
GB1365661A (en) Prparation of medicinal and food compositions
IL47015A (en) Derivatives of phenthylamino-ketones and phenthylamino-dioxolanes,their preparation and pharmaceutical compositions containing them
IL44222A (en) Diphenylpropylamines their preparation and pharmaceutical compositions containing them
IL47826A (en) 7-aminoalkoxy-chroman and-tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them
IL43218A0 (en) New derivatives of 2-amino-indane,their preparation and pharmaceutical compositions containing them
IL40572A0 (en) Biphenylyl-butanols,their preparation and pharmaceutical compositions containing them
CY1110A (en) Cinnamamides their preparation and pharmaceutical compositions containing them
IL45950A (en) 2-glycylamido-4-pyridyl-thiazole derivatives their preparation and pharmaceutical compositions containing them
IL50732A (en) Disubstituted phenol ethers of 3 amino-2-hydroxypropane their preparation and pharmaceutical compositions containing them
IL37830A (en) Derivatives of 1-phenoxy-2-hydroxy-3-amino-propane,their preparation and pharmaceutical compositions containing them
IL38593A0 (en) Substituted 2-arylamino-imidazoline-(2)derivatives,their preparation and pharmaceutical compositions containing them
IL46292A0 (en) Derivatives of 1-phenoxy-3-aminopropan-2-ol,their preparation and pharmaceutical compositions containing them
IL37431A0 (en) New derivatives of thiazolino-pyrimidin-5-one,their preparation and pharmaceutical compositions containing them